Intellia Therapeutics, Inc. (NTLA)

13.42 -0.16 (-1.18%) USD  |  NASDAQ  |  Feb 25, 16:00
13.97 +0.55 (+4.10%) Pre-Market: 08:32
More

Intellia Therapeutics Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Beam Therapeutics, Inc. Upgrade
Personalis, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. --
Twist Bioscience Corp. Upgrade